Jin Mingjuan, Ye Ding, Li Yingjun, Jing Fangyuan, Jiang Xiyi, Gu Simeng, Mao Yingying, Li Qilong, Chen Kun
Department of Epidemiology and Health Statistics, Zhejiang University School of Public Health, Hangzhou, China.
Department of Public Health, Hangzhou Medical School, Hangzhou, China.
Gene. 2017 Aug 15;624:21-25. doi: 10.1016/j.gene.2017.04.036. Epub 2017 Apr 23.
This study aimed to investigate the associations of selected polymorphisms in RP11-650L12.2 with the risk of colorectal cancer (CRC) in a Chinese population.
A total of 821 CRC cases (test set: 320, validation set: 501) and 857 healthy controls (test set: 319, validation set: 538) were enrolled in this study. Demographic characteristics and lifestyle information were collected by a validated questionnaire. A sample of 5ml venous blood was collected from each subject for DNA isolation, and the selected polymorphisms (rs144182521, rs514743, rs76071148, rs149941240) were genotyped by MassArray technique.
The rs149941240 polymorphism was significantly associated with the risk of CRC, with ORs of 1.50 (95% CI: 1.15-1.96) by co-dominant model and 1.45 (95% CI: 1.21-1.87) by dominant model in the test set, respectively. Correspondingly, the ORs were 1.48 (95% CI: 1.19-1.82) and 1.41 (95% CI: 1.15-1.73) in the validation set, respectively. The crossover analysis showed that non-smokers with the variant genotypes in rs149941240 had a significantly increased risk of CRC than those with wild genotype by dominant model in the validation set (OR 1.42, 95% CI 1.04-1.96). However, no gene-environment multiplicative interactions of rs149941240 with tobacco smoking were found on risk of CRC.
Our findings suggest that rs149941240 polymorphism was associated with the risk of CRC, and might contribute to the susceptibility to CRC. The effects of this polymorphism should be validated in a larger sample and require further mechanistic investigations to determine the nature of its influence on CRC.
本研究旨在探讨中国人群中RP11-650L12.2基因中特定多态性与结直肠癌(CRC)风险之间的关联。
本研究共纳入821例CRC患者(测试集:320例,验证集:501例)和857名健康对照者(测试集:319名,验证集:538名)。通过经过验证的问卷收集人口统计学特征和生活方式信息。从每位受试者采集5ml静脉血用于DNA分离,并采用MassArray技术对选定的多态性(rs144182521、rs514743、rs76071148、rs149941240)进行基因分型。
rs149941240多态性与CRC风险显著相关,在测试集中,共显性模型的比值比(OR)为1.50(95%置信区间:1.15-1.96),显性模型的OR为1.45(95%置信区间:1.21-1.87)。相应地,在验证集中,OR分别为1.48(95%置信区间:1.19-1.82)和1.41(95%置信区间:1.15-1.73)。交叉分析显示,在验证集中,rs149941240基因变异型的非吸烟者患CRC的风险比野生型显著增加(显性模型,OR 1.42,95%置信区间1.04-1.96)。然而,未发现rs149941240与吸烟之间在CRC风险上存在基因-环境相乘交互作用。
我们的研究结果表明,rs149941240多态性与CRC风险相关,可能导致CRC易感性增加。这种多态性的影响应在更大样本中进行验证,并需要进一步的机制研究以确定其对CRC影响的性质。